stockrowImmunic, Inc. (IMUX) vs NRx Pharmaceuticals, Inc. (NRXP)
- Immunic, Inc. IMUX 7.38 −7.05%
- NRx Pharmaceuticals, Inc. NRXP 2.31 −7.23%
Immunic, Inc. and NRx Pharmaceuticals, Inc. are both Biotechnology companies. Immunic, Inc. and NRx Pharmaceuticals, Inc. are of similar size ($99.9M and $98.3M). Immunic, Inc. has the higher net margin (0.00% vs −691.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Immunic, Inc. leads on 6 and NRx Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | IMUX | NRXP | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 46.64% | 65.16% |
| Operating margin | 0.00% | (586.15%) | 0.00% |
| Net margin | 0.00% | (691.78%) | 0.00% |
| Free cash flow margin | 0.00% | (609.02%) | 0.00% |
| Return on equity | (138.17%) | 131.22% | (50.12%) |
| Return on assets | (101.15%) | (120.41%) | (45.60%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack